Number of the records: 1  

Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP

  1. 1.
    SYSNO0503586
    TitleAcquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
    Author(s) Piggott, L. (GB)
    Silva, A. (GB)
    Robinson, T. (GB)
    Santiago-Gomez, A. (GB)
    Simoes, B. M. (GB)
    Becker, M. (DE)
    Fichtner, I. (DE)
    Anděra, Ladislav (BTO-N)
    Young, P. (GB)
    Morris, Ch. (GB)
    Barrett-Lee, P. (GB)
    Alchami, F. (GB)
    Piva, M. (ES)
    Vivanco, M. D. (ES)
    Clarke, R. B. (GB)
    Gee, J. (GB)
    Clarkson, R. (GB)
    Source Title Clinical Cancer Research. Roč. 24, č. 10 (2018), s. 2452-2463. - : American Association for Cancer Research
    Document TypeČlánek v odborném periodiku
    Institutional supportBTO-N - RVO:86652036
    Languageeng
    CountryUS
    Keywords FLICE inhibitory protein recombinant tumor necrosis factor related apoptosis inducing ligand * fulvestrant * recombinant tumor necrosis factor related apoptosis inducing ligand
    Permanent Linkhttp://hdl.handle.net/11104/0295402
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.